NASDAQ: BEAM
Beam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?

Insider buying vs selling

Have Beam Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy SimonMed2026-07-2716,667$25.74
$429.04kSell
John M. EvansCEO2026-06-3023,100$34.26
$791.48kSell
John M. EvansCEO2026-06-301,900$34.84
$66.20kSell
Amy SimonChief Medical Officer2026-06-30373$34.73
$12.95kSell
John M. EvansCEO2026-06-3025,000$1.03
$25.75kBuy
John M. EvansCEO2026-06-2913,421$35.13
$471.53kSell
John M. EvansCEO2026-06-2918,663$0.67
$12.50kBuy
John M. EvansCEO2026-06-2911,579$35.91
$415.83kSell
John M. EvansCEO2026-06-296,337$1.03
$6.53kBuy
Fmr LLC10% Owner2026-06-26251,488$35.26
$8.87MSell

1 of 5

BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BEAM insiders and whales buy or sell their stock.

BEAM Shareholders

What type of owners hold Beam Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC4.33%4,467,741$118.71MInsider
Robert Nelsen3.42%3,535,572$93.94MInsider
Arch Venture Partners IX LLC2.86%2,949,630$78.37MInsider
Kristina Burow2.66%2,747,530$73.00MInsider
Redmile Group LLC1.12%1,161,458$30.86MInsider
John M. Evans1.11%1,150,205$30.56MInsider
Giuseppe Ciaramella0.25%253,911$6.75MInsider
Christine Bellon0.11%109,711$2.92MInsider
Sravan Kumar Emany0.10%105,456$2.80MInsider
Amy Simon0.08%85,696$2.28MInsider

1 of 3

BEAM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BEAM0.11%16.19%Net SellingNet Selling
VRDN0.12%31.97%Net Buying
ATAI0.04%32.44%Net BuyingNet Buying
NRIX0.11%8.16%Net SellingNet Selling
TRVI0.09%99.91%Net Buying

Beam Therapeutics Stock Ownership FAQ

Who owns Beam Therapeutics?

Beam Therapeutics (NASDAQ: BEAM) is owned by 0.11% institutional shareholders, 16.19% Beam Therapeutics insiders, and 83.71% retail investors. Fmr LLC is the largest individual Beam Therapeutics shareholder, owning 4.47M shares representing 4.33% of the company. Fmr LLC's Beam Therapeutics shares are currently valued at $118.71M.

If you're new to stock investing, here's how to buy Beam Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.